Tci Wealth Advisors, Inc. Morphic Holding, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$19.74 - $43.01 $2,921 - $6,365	148 New	148 $3,000
Q4 2021 Jan 24, 2022	SELL	$43.27 - $65.72 $3,245 - $4,929	-75 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$53.61 - $67.5 $4,020 - $5,062	75 New	75 $4,000
Q2 2021 Aug 02, 2021	SELL	$45.13 - $64.99 $1,308 - $1,884	-29 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$29.77 - $84.85 $863 - $2,460	29 New	29 $2,000

140

38.7M

4.2K

200K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.